Cargando…
Targeting c-Myc with a novel Peptide Nuclear Delivery Device
Biologics such as peptides and antibodies are a well-established class of therapeutics. However, their intracellular delivery remains problematic. In particular, methods to efficiently inhibit intra-nuclear targets are lacking. We previously described that Pseudomonas Exotoxin A reaches the nucleopl...
Autores principales: | Ting, Trinda Anne, Chaumet, Alexandre, Bard, Frederic Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576588/ https://www.ncbi.nlm.nih.gov/pubmed/33082422 http://dx.doi.org/10.1038/s41598-020-73998-x |
Ejemplares similares
-
Nuclear envelope-associated endosomes deliver surface proteins to the nucleus
por: Chaumet, Alexandre, et al.
Publicado: (2015) -
The NAE Pathway: Autobahn to the Nucleus for Cell Surface Receptors
por: Shah, Poonam, et al.
Publicado: (2019) -
Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex
por: Dutta, Debasish, et al.
Publicado: (2018) -
Targeting c-MYC with T-Cells
por: Helm, Florian, et al.
Publicado: (2013) -
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer
por: Esser, Alison K., et al.
Publicado: (2020)